GILD
Gilead Sciences, Inc. · Healthcare · Drug Manufacturers - General
Données momentum (gérants comparables) :
étendue des détenteurs +5.3% ·
flux d'actions -1.3% ·
nouvelles positions nettes +5.0%
— formule
Fragmentation de l'actionnariat — plus de détenteurs, participation agrégée plus faible
Toutes les données de détention : gérants 13F suivis uniquement, positions en actions ordinaires, période de référence Q4 2024
| Trimestre | Détenteurs | Δ | Actions | Valeur déclarée | Nouveau | Sorties |
|---|---|---|---|---|---|---|
| Q2 2026 | 175 | +1 | 941.71M | $119.07B | +5 | −3 |
| Q1 2026 | 176 | +4 | 930.86M | $129.53B | +6 | −3 |
| Q4 2025 | 171 | 0 | 1.00B | $122.89B | +1 | — |
| Q3 2025 | 23 | -1 | 603.99M | $67.03B | — | −2 |
| Q2 2025 | 22 | -1 | 560.26M | $62.11B | — | −1 |
| Q1 2025 | 20 | 0 | 255.31M | $28.60B | — | — |
| Q4 2024 | 20 | +1 | 270.33M | $24.97B | +1 | — |
| Q3 2024 | 18 | 0 | 213.42M | $17.89B | — | — |
| Q2 2024 | 18 | — | 202.41M | $13.88B | — | — |
| # | Gérant | Actions | Δ actions | Valeur | Leur poids | Détenu | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 71.71M | -6.3% | $6.62B | 1.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passif) | 60.38M | — | $5.58B | 0.2% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 35.66M | +3.1% | $3.29B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 35.66M | +3.1% | $3.29B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 35.66M | +3.1% | $3.29B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 35.66M | +3.1% | $3.29B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 35.66M | +3.1% | $3.29B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 35.66M | +3.1% | $3.29B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 35.66M | +3.1% | $3.29B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 35.66M | +3.1% | $3.29B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 35.66M | +3.1% | $3.29B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 12 | Dodge & Cox ✦ | 32.95M | -0.3% | $3.04B | 1.8% | ▼ Trim | 3 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passif) | 28.29M | +2.7% | $2.61B | 0.2% | ▲ Add | 3 | SEC ↗ |
| 14 | Geode Capital Management ✦ (passif) | 28.29M | +2.7% | $2.61B | 0.2% | ▲ Add | 3 | SEC ↗ |
| 15 | Norges Bank ✦ (passif) | 19.37M | +9.4% | $1.79B | 0.2% | ▲ Add | 3 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 5.33M | +27.2% | $492.31M | 0.7% | ▲ Add | 3 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 4.70M | -6.4% | $433.76M | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 4.70M | -6.4% | $433.76M | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 3.55M | +5.9% | $327.61M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 3.55M | +5.9% | $327.61M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 1.81M | -6.7% | $167.52M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 1.81M | -6.7% | $167.52M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 1.81M | -6.7% | $167.52M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 1.81M | -6.7% | $167.52M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 1.81M | -6.7% | $167.52M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 26 | Adage Capital Partners ✦ | 1.71M | Nouveau | $158.33M | 0.3% | New | 1 | SEC ↗ |
| 27 | Marshall Wace ✦ | 1.22M | +18.9% | $112.40M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 28 | Marshall Wace ✦ | 1.22M | +18.9% | $112.40M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 29 | Marshall Wace ✦ | 1.22M | +18.9% | $112.40M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 1.01M | +36.6% | $93.52M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 31 | D. E. Shaw & Co. ✦ | 1.01M | +36.6% | $93.52M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 32 | Point72 Asset Management ✦ | 856.66K | -62.8% | $79.13M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 33 | Millennium Management ✦ | 682.51K | -45.1% | $63.04M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 34 | Bridgewater Associates ✦ | 460.94K | +122.7% | $42.58M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 35 | Gotham Asset Management ✦ | 256.04K | +0.3% | $23.65M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 36 | Two Sigma Investments ✦ | 239.96K | -65.7% | $22.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 37 | Arrowstreet Capital ✦ | 139.61K | -95.3% | $12.90M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 38 | Fisher Asset Management ✦ | 10.61K | +18.5% | $979,740 | 0.0% | ▲ Add | 3 | SEC ↗ |
« Leur pondération » = la part de la position dans la valeur des actions 13F déclarées de ce gérant — la mesure de conviction. ✦ = gérant sélectionné.
Nouveaux acheteurs
| Adage Capital Partners | $158.33M | 0.3% |
Sorti(e)
| Aucune sortie suivie ce trimestre. |
Contexte marché global: parmi TOUS les déposants 13F (données structurées SEC, Q1 2026): 1 détenteurs, 61.30K actions, $8,543 déclaré. Il s'agit d'une période différente et plus ancienne que les chiffres de l'univers suivi ci-dessus ; les deux ne sont jamais mélangés.
Ce que les détenteurs suivis de ce titre détiennent le plus souvent par ailleurs — nombre de détentions partagées, sans relation fondamentale sous-jacente.
Achats sur le marché libre (P)
Aucun achat d'initié sur le marché libre dans notre fenêtre de couverture.
Ventes sur le marché libre (S)
Director · 1.17K act. · $167,474
Director · 1.82K act. · $263,183
Director · 1.66K act. · $241,618
Director · 26 act. · $3,805
Director · 335 act. · $48,997
Officer · 3.00K act. · $415,080
Officer · 16.53K act. · $2.27M
Officer · 11.47K act. · $1.58M
Les attributions, exercices et retenues fiscales ne sont jamais comptabilisés comme des achats ou des ventes ici. Méthodologie